View of Risk of Hepatocellular Carcinoma Recurrence After the Use of Direct-Acting Antivirals in the Treatment of Hepatitis C: Systematic Review and Metanalysis

Return to Article Details Risk of Hepatocellular Carcinoma Recurrence After the Use of Direct-Acting Antivirals in the Treatment of Hepatitis C: Systematic Review and Metanalysis Download Download PDF